PC 114

Drug Profile

PC 114

Alternative Names: PC-114

Latest Information Update: 15 Aug 2016

Price : $50

At a glance

  • Originator PinCell
  • Class Anti-inflammatories; Skin disorder therapies
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Psoriasis

Highest Development Phases

  • Research Psoriasis

Most Recent Events

  • 15 Aug 2016 Early research in Psoriasis in Italy (Topical)
  • 15 Aug 2016 PC 114 is available for licensing as of 15 Aug 2016. https://sites.google.com/site/pincellsite/
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top